These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35983548)

  • 1. Evaluation of the effectiveness of platelet crossmatching by the solid-phase red cell adherence assay in adult patients of a tertiary care hospital in Thailand: A retrospective study.
    Sinwatcharaphirom T; Apisawes K; Kittivorapart J
    Health Sci Rep; 2022 Sep; 5(5):e769. PubMed ID: 35983548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Human Leucocyte Antigen Mediated Platelet Transfusion Refractoriness and Platelet Crossmatching Assay in Patients with Hematologic Disorders.
    Neanaey WA; Deghady AA; Nafea DA; Fahmy NM; Gouda AM
    Oman Med J; 2022 Jul; 37(4):e402. PubMed ID: 35915764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of platelet crossmatch results by Solid Phase Red Cell Adherence Assay (SPRCA) with post-transfusion platelet count increment in adult hemato-oncology patients of a tertiary care oncology centre in India.
    Desai P; Sontakke P; Rajadhyaksha S; Navkudkar A
    Transfus Apher Sci; 2020 Oct; 59(5):102842. PubMed ID: 32586771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of cross-match compatible platelets in multi transfused haemato-oncology patients refractory to platelet transfusion.
    Chavan A; Sharma RR; Saikia B; Malhotra P; Prakash S; Hans R; Marwaha N
    Transfus Apher Sci; 2019 Dec; 58(6):102657. PubMed ID: 31706911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: solid-phase platelet crossmatching to support the alloimmunized patient.
    O'Connell BA
    Immunohematology; 1995; 11(4):150-2. PubMed ID: 15447057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establish a Graded Method to Avoid HLA Class I Antibodies Corresponding Antigen and Combining HLAMatchmaker Application in Improving the CCI Value after Platelet Transfusion for Patients with IPTR].
    Gao SQ; Xu YP; Luo CR; Li DC; Pen L; Liu T; Zou QC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):242-249. PubMed ID: 38387929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
    Yung CH; Chow MP; Hu HY; Tzeng JL; Mou LL; Deng JM
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):228-36. PubMed ID: 1646671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
    Wiita AP; Nambiar A
    Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of platelet cross-matching in the management of patients refractory to platelet transfusions.
    Salama OS; Aladl DA; El Ghannam DM; Elderiny WE
    Blood Transfus; 2014 Apr; 12(2):187-94. PubMed ID: 24931840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.
    Gelb AB; Leavitt AD
    Transfusion; 1997 Jun; 37(6):624-30. PubMed ID: 9191823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
    Heal JM; Blumberg N; Masel D
    Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization.
    Friedberg RC; Donnelly SF; Boyd JC; Gray LS; Mintz PD
    Blood; 1993 Jun; 81(12):3428-34. PubMed ID: 8507878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for platelet antibodies in adult idiopathic thrombocytopenic purpura: a comparative study using solid phase red cell adherence assay and flow cytometry.
    Lin JS; Lyou JY; Chen YJ; Chen PS; Liu HM; Ho CH; Hao TC; Tzeng CH
    J Chin Med Assoc; 2006 Dec; 69(12):569-74. PubMed ID: 17182350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a solid phase red cell adherence technique for platelet antibody screening.
    Lown JA; Ivey JG
    Transfus Med; 1991 Sep; 1(3):163-7. PubMed ID: 9259843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet antibody screening by flow cytometry is more sensitive than solid phase red cell adherence assay and lymphocytotoxicity technique: a comparative study in Thai patients.
    Buakaew J; Promwong C
    Asian Pac J Allergy Immunol; 2010; 28(2-3):177-84. PubMed ID: 21038788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-match-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.
    Elhence P; Chaudhary RK; Nityanand S
    Blood Transfus; 2014 Apr; 12(2):180-6. PubMed ID: 24333069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of platelet alloantibody in multiply-transfused haematology patients.
    Linn YC; Prakash P; Ong YW
    Ann Acad Med Singap; 1995 Mar; 24(2):305-11. PubMed ID: 7653976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.